# US 2015/0104434 A1 · Artificial kidney precursor and process for production thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104434 A1
- Document ID: US20150104434A1
- Status: Published application
- Kind: A1
- Application number: 14/565,104
- Filed: 2014-12-09
- Published: 2015-04-16
- Earliest claimed: 2008-07-02
- Assignees: Otsuka Pharmaceutical Factory, Inc.; Jichi Medical University; The Jikei University; Tokyo Women's Medical University
- Applicants: Otsuka Pharmaceutical Factory, Inc.; Jichi Medical University; The Jikei University; Tokyo Women's Medical University
- Inventors: Eiji KOBAYASHI; Takashi YOKOO; Koutaro KAI
- Web page: https://patentgrep.com/patent/US20150104434A1

## CPC

- A61P 13/12: of the kidneys
- C12N 5/0697: {Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691)}
- A61K 35/22: Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
- C12N 5/0686: {Kidney cells}
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- C12N 2502/02: embryonic cells
- C12N 2506/1346: from mesenchymal stem cells
- C12N 2523/00: Culture process characterised by temperature
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides an artificial kidney precursor containing a non-human mammalian metanephros separated out from a living body, wherein the metanephros has been subjected to freezing and thawing treatments outside a living body, and contains mammalian mesenchymal stem cells transferred outside a living body, and a method of production thereof.

## Claims

### Claim 1

A method of producing an artificial kidney precursor that is to be transplanted to a human recipient, the precursor comprising:
a non-human mammalian metanephros comprising blast cells of a kidney; and
mammalian mesenchymal stem cells isolated from the recipient, which method comprises the steps of:
(I) freezing the non-human mammalian metanephros comprising blast cells of a kidney, said metanephros being separated out from a living body;
(II) thawing the frozen mammalian metanephros; and
(III) transferring said mammalian mesenchymal stem cells into the metanephros comprising blast cells of a kidney, outside a living body before the freezing (I) or after the thawing (II), thereby obtaining the artificial kidney precursor.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the metanephros used in (I) is a metanephros separated out from a non-human mammalian embryo in a stage where the expression of WIC is still immature.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the artificial kidney precursor is capable of acquiring a potential for erythropoietin production when transplanted into an omentum of the human recipient.

### Claim 4 (depends on 1)

The method according to claim 1, further comprising transplanting the obtained artificial kidney precursor into the human recipient.
